Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals

Autonomic and Autacoid Pharmacology

Volumn 23, Issue 4, 2003, Pages 201-207

  Demehri, S ^a   Samini, M ^a   Namiranian, K ^a   Rastegar, H ^b   Mehr, S E ^a   Homayoun, H ^a   Roushanzamir, F ^b   Jorjani, M ^c   Dehpour, A R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

2 adrenoceptors; Cholestasis; Guinea pig ileum; Mice vas deferens; Nitric oxide

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALTREXONE; NITRIC OXIDE; OPIATE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DRUG SENSITIVITY; ELECTROSTIMULATION; GUINEA PIG; ILEUM CONTRACTION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; VAS DEFERENS;

ANALGESICS, OPIOID; ANIMALS; CHOLESTASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; ILEUM; MALE; MICE; MORPHINE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID; VAS DEFERENS;

EID: 2342642683     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2003.00297.x     Document Type: Article

References (41)

1. ALGUACIL, L.F., ALAMO, C., SANTOS, C. & CUENCA, E. (1987). Yohimbine reduces morphine tolerance in guinea-pig ileum. Life Sci., 40, 155-160.
2. BABEY, A.M., KOLESNIKOV, Y., CHENG, J., INTURRISI, C.E., TRIFILLETTI, R.R. & PASTERNAK, G.W. (1994). Nitric oxide and opioid tolerance. Neuropharmacology, 33, 1463-1470.
3. BERGASA, N.V., ROTHMAN, R.B., VERGALLA, J., XU, H., SWAIN, M.G. & JONES, E.A. (1992). Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J. Hepatol., 15, 220-224.
4. BERGASA, N.V., ALLING, D.W., VERGALLA, J. & JONES, E.A. (1994). Cholestasis in the male rat is associated with naloxone-reversible antinociception. J. Hepatol., 20, 85-90.
5. CAPASSO, A., SORRENTINO, L. & PINTO, A., 1998. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with μ- and κ-opioid receptor agonists. Eur. J. Pharmacol., 359, 127-131.
6. CLEMENT-JONES, V., LOWRY, P.J., REES, L.H. & BESSER, G.M. (1980). Met-enkephalin circulates in human plasma. Nature, 283, 295-297.
7. COX, B.M. (1978). Stimulus-response relationships in ileum preparations from normal and morphine treated guinea-pigs. Br. J. Pharmacol., 62, 387-388.
8. DEHPOUR, A.R., AKBARLOO, N. & GHAFOURIFAR, P. (1998). Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis. Behav. Pharmacol., 9, 77-80.
9. DEHPOUR, A.R., RASTEGAR, H., JORJANI, M., ROUSHANZAMIR, F., JOHARCHI, K. & AHMADIANI, A. (2000). Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis. J. Pharmacol. Exp. Ther., 293, 946-951.
10. DEHPOUR, A.R., SAMINI, M., ARAD, M.A. & NAMIRANIAN, K. (2001). Clonidine attenuates naloxone-induced opioid-withdrawal syndrome in cholestatic mice. Pharmacol. Toxicol., 89, 129-132.
11. DEHPOUR, A.R., SADR, S.S., AZIZI, M.R., NAMIRANIAN, K., FARAHANI, M. & JAVIDAN, A.N. (2002). Lithium inhibits the development of physical dependence to clonidine in mice. Pharmacol. Toxicol., 90, 89-93.
12. DEMEHRI, SH., NAMIRANIAN, KH., EJTEMAEI MEHR, SH., RASTEGAR, H., SHARIFTABRIZI, A., GASKARI, S.A., ROSHANZAMIR, F. & DEHPOUR, A.R. (2003). Alpha-2-adrenoceptorhyporesponsiveness in isolated tissues of cholestatic animals: involvement of opioid and nitric oxide systems. Life. Sci., 77, 209-220.
13. DUARTE, I.D. & FERREIRA, S.H. (1992). The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol., 221, 171-174.
14. DUARTE, I.D., DOS SANTOS, I.R., LORENZETTI, B.B. & FERREIRA, S.H. (1992). Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol., 217, 225-227.
15. ELLIOTT, K., MINAMI, N., KOLESNIKOV, Y.A., PASTERNAK, G.W. & INTURRISI, C.E. (1994). The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain, 56, 69-75.
16. GASKARI, S.A., MANI, A.R., MEHR, S.E., NAMIRANIAN, K., HOMAYOUN, H., AHMADI, H. & DEHPOUR, A.R. (2002). Does endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis? Fund. Clin. Pharmacol., 16, 273-279.
17. GHAFOURIFAR, P., DEHPOUR, A.R. & AKBARLOO, N. (1997). Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis. Life Sci., 60, 265-270.
18. GOLDSTEIN, A. & SCHULZ, R. (1973). Morphine-tolerant longitudinal muscle strip from guinea-pig ileum. Br. J. Pharmacol., 48, 655-666.
19. HOMAYOUN, H., SAYYAH, M. & DEHPOUR, A.R. (2002). The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice. J. Gastroenterol. Hepatol., 17, 96-101.
20. KESNER, R.P. & PRIANO, D.J. (1977). Disruptive effects of naloxone on development of morphine tolerance. Life Sci., 21, 509-512.
21. KIHARA, T. & KANETO, H. (1986). Important role of adrenergic function in the development of analgesic tolerance to morphine in mice. Jpn. J. Pharmacol., 42, 419-423.
22. KOLESNIKOV, Y.A., PICK, C.G. & PASTERNAK, G.W. (1992). NG-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol., 221, 399-400.
23. KOLESNIKOV, Y.A., PICK, C.G., CISZEWSKA, G. & PASTERNAK, G.W. (1993). Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. USA, 90, 5162-5166.
24. MUSHLIN, B.E. & COCHIN, J. (1976). Tolerance to morphine in the rat: its prevention by naloxone. Life Sci., 18, 797-801.
25. NAHAVANDI, A., MANI, A.R., HOMAYOUNFAR, H., AKBARI, M.R. & DEHPOUR, A.R. (2001). The role of the interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats. Fundam. Clin. Pharmacol., 15, 181-187.
26. NAMIRANIAN, K., SAMINI, M., MEHR, S.E., GASKARI, S.A., RASTEGAR, H., HOMAYOUN, H. & DEHPOUR, A.R. (2001). Mesenteric vascular bed responsiveness in bile ductligated rats: roles of opioid and nitric oxide systems. Eur. J. Pharmacol., 423, 185-193.
27. NEHER, E. (1988). The use of the patch clamp technique to study second messenger-mediated cellular events. Neuroscience, 26, 727-734.
28. NICOLL, R.A. (1988). The coupling of neurotransmitter receptors to ion channels in the brain. Science, 241, 545-551.
29. POWELL, K.J., ABUL-HUSN, N.S., JHAMANDAS, A., OLMSTEAD, M.C., BENINGER, R.J. & JHAMANDAS (2002). Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J. Pharmacol. Exp. Ther., 300, 588-596.
30. REZVANI, A., HUIDOBRO-TORO, J.P., HU, J. & WAY, E.L. (1983). A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro. J. Pharmacol. Exp. Ther., 225, 251-255.
31. RUBINI, P., SCHULZ, R., WUSTER, M. & HERZ, A. (1982). Opiate receptor binding studies in the mouse vas deferens exhibiting tolerance without dependence. Naunyn Schmiedebergs Arch. Pharmacol., 319, 142-146.
32. SCHULZ, R. & HERZ, A. (1976). Aspects of opiate dependence in the myenteric plexus of the guinea-pig. Life Sci., 19, 1117-1127.
33. SCHULZ, R., CARTWRIGHT, C. & GOLDSTEIN, A. (1974). Reversibility of morphine tolerance and dependence in guinea pig brain and myenteric plexus. Nature, 251, 329-331.
34. SCHULZ, R., WUSTER, M., KRENSS, H. & HERZ, A. (1980). Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature, 285, 242-243.
35. SOLOMON, R.E. & GEBHART, G.F. (1988). Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure. J. Pharmacol. Exp. Ther., 245, 444-454.
36. SURPRENANT, A. & NORTH, R.A. (1985). mu-Opioid receptors and alpha 2-adrenoceptors coexist on myenteric but not on submucous neurones. Neuroscience, 16, 425-430.
37. SWAIN, G. (1994). Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis. Hepatology, 20, 700-705.
38. SWAIN, G., XU, H., VERGALLA, J., BERGASA, N.V. & JONES, E.A. (1992). Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology, 103, 630-635.
39. THORAT, S.N., REDDY, P.L. & BHARGAVA, H.N. (1993). Evidence for the role of nitric oxide in kappa-opiate tolerance in mice. Brain Res., 621, 171-174.
40. THORNTON, J.R. & LOSOWSKY, M.S. (1988). Opioid peptides and primary biliary cirrhosis. Br. Med. J., 297, 1501-1504.
41. TSENG, L.F., XU, J.Y. & PIEPER, G.M. (1992). Increase of nitric oxide production by L-arginine potentiates i.c.v. administered beta-endorphin-induced antinociception in the mouse. Eur. J. Pharmacol., 212, 301-303.